Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1664108

Circulating NETs Enable Early Identification of Thrombotic Risk in Sepsis at Emergency Care Onset

Provisionally accepted
Sofía  TejadaSofía Tejada1Antonio  ClementeAntonio Clemente2*Antonia  SociasAntonia Socias3Maria  ArandaMaria Aranda3Alberto  Del CastilloAlberto Del Castillo3Joana  MenaJoana Mena3Joana  Mª RibasJoana Mª Ribas4Luisa  MartínLuisa Martín4Karla  Milagritos LlerenaKarla Milagritos Llerena4María  Magdalena ArellanoMaría Magdalena Arellano4Miguel  AgudoMiguel Agudo4Roberto  De La RicaRoberto De La Rica5Marcio  BorgesMarcio Borges3
  • 1Multidisciplinay Sepsis Group, Fundacio Institut d'Investigacio Sanitaria Illes Balears, Palma, Spain
  • 2Group of Innovation in Immunopathology of Infections (GTERi), Fundacio Institut d'Investigacio Sanitaria Illes Balears, Palma, Spain
  • 3Multidisciplinay Sepsis Unit, Hospital Son Llatzer, Palma, Spain
  • 4Emergency Department, Hospital Son Llatzer, Palma, Spain
  • 5Multidisciplinary Sepsis Group, Fundacio Institut d'Investigacio Sanitaria Illes Balears, Palma, Spain

The final, formatted version of the article will be published soon.

Introduction: Sepsis involves a dysregulated host response to infection and is frequently complicated by coagulopathy, contributing to organ dysfunction and mortality. Early detection of coagulation disturbances in the emergency department (ED) remains clinically challenging. Neutrophil extracellular traps (NETs) have emerged as key mediators linking inflammation and thrombosis in sepsis, yet their prognostic value during early care is unclear. This study aimed to assess whether circulating NETs measured at sepsis onset are associated with inflammatory biomarkers, sepsis-induced coagulopathy (SIC) status, and clinical outcomes. Methods: We conducted a retrospective study including 212 adult patients with sepsis recruited at the ED presentation. Plasma NETs, IL-6, and MR-ProADM were measured by ELISA. The ISTH SIC score was used to identify early-stage coagulopathy. Results: Circulating NETs were detected in 61 patients (28.8%) and higher NETs levels were significantly associated with elevated D-dimer, LDH, IL-6, PCT, and hypocholesterolemia. NETs positive patients had increased odds of positive blood cultures (OR = 2.3; 95% CI: 1.2–2.5), thromboembolic events (OR = 4.4; 95% CI: 1.0–19.0), and SOFA ≥ 5 (OR = 2.0; 95% CI: 1.1–2.9). Among 202 patients with complete data to SIC evaluation, 49% met SIC criteria. Although NETs were not independently associated with SIC, their inflammatory and clinical impact was significantly amplified in SIC-positive patients, suggesting a synergetic interaction between NETosis and early coagulopathy. Discussion: NETs quantification at ED presentation may help identify a high-risk immunothrombotic phenotype in sepsis and support earlier NETosis-targeted therapies alongside anticoagulation.

Keywords: Sepsis, Coagulopathy NETosis, NETs, biomarkers, emergency department

Received: 11 Jul 2025; Accepted: 13 Oct 2025.

Copyright: © 2025 Tejada, Clemente, Socias, Aranda, Del Castillo, Mena, Ribas, Martín, Milagritos Llerena, Arellano, Agudo, De La Rica and Borges. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Antonio Clemente, antonio.clemente@idisba.es

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.